340040-67-7

Basic information

• Product Name: (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride
• Synonyms: (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride;(2R)-2-Pyrrolidineacetic acid methyl ester hydrochloride;(R)-Methyl 2-pyrrolidineacetate HCl
• CAS NO: 340040-67-7
• Molecular Formula: C₇H₁₃NO₂*ClH
• Molecular Weight: 179.64456
• Mol File: 340040-67-7.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride(340040-67-7)
• EPA Substance Registry System: (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride(340040-67-7)

Safety Data

• Hazardous Substances Data: 340040-67-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride is used as a key intermediate for the synthesis of enantiomeric 2-pyrrolidineacetic acids. These acids are essential components in the development of chiral drugs, which have specific therapeutic effects due to their unique spatial arrangement. (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride plays a crucial role in ensuring the correct stereochemistry of the final product, leading to improved efficacy and reduced side effects.
Used in Chemical Research:
In the field of chemical research, (R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride serves as a versatile reagent for exploring new reaction pathways and developing innovative synthetic methods. Its unique structural features allow chemists to investigate various aspects of asymmetric synthesis, catalysis, and molecular recognition, contributing to the advancement of chemical science and technology.
Used in Drug Development:
(R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride is also utilized in drug development as a precursor for the creation of novel bioactive molecules with potential applications in various therapeutic areas. Its chiral nature enables the design of targeted drugs that can interact specifically with biological receptors, enzymes, or other molecular targets, leading to more effective treatments with fewer side effects.

Upstream product

• 67-56-1 methanol 
• 1174705-02-2 2-[(2R)-1-methylpyrrolidin-2-yl]acetic acid 
• 132482-05-4 methyl (R)-2-[N(1')-(tert-butoxycarbonyl)pyrrolidin-2'-yl]ethanoate 

Relevant articles and documents

SUBSTITUTED PYRIMIDODIAZEPINES

The present invention provides PLK1 inhibitor compounds of formula I: Useful in the treatment or control of cell proliferative disorders, particularly oncological disorders. These compounds and formulations containing such compounds may be useful in the t

N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa

This invention is directed to N-acylpyrrolidin-2-ylalkylbenzamidine derivatives which useful for inhibiting the activity of Factor Xa, by contacting said derivatives with a composition containing Factor Xa. The present invention is also directed to compositions containing said derivatives, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.

N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa

This invention is directed to N-acylpyrrolidin-2-ylalkylbenzamidine derivatives which useful for inhibiting the activity of Factor Xa, by contacting said derivatives with a composition containing Factor Xa. The present invention is also directed to compos